3Mackstaller LL,Alpert JS.Atrial fibrillation:a review of mechanism,etiology,and therapy[J].Clin Cardiol,1997,20:640-650.
4AFFIRM First Antiarrhythmic Drug Substudy Investigators.Maintenance of sinus rhythm in patients with atrial fibrillation:an AFFIRM substudy of the first antiarrhythmic drug[J].J Am Coll Cardiol,2003,42:20-29.
5Nichol G,McAlister F,Pham B,et al.Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation[J].Heart,2002,87:535-543.
6Hirsh J,Fuster V,Ansell J,et al.American Heart Association/American College of Cardiology Foundation guide to warfarin therapy[J].J Am Coll Cardiol,2003,41:1633-1652.
7Petersen P,Grind M,Adler J.Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation.SPORTIF Ⅱ:a dose-guiding,tolerability,and safety study[J].J Am Coll Cardiol,2003,41:1445-1451.
8Arboix A,Lluis GE,Massons JB,et al.Atrial fibrillation and stroke:clinical presentation of cardioembolic versus atherothrombotic infarction.Int J Cardiol,2000,73:33-42.
9Petersen P,Boysen G,Godtfredsen J,et al.Placebo controlled,randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation.Lancet,1989,338:175-179.
10European Atrial Fibrillation Trial Study Group.Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke.Lancet,1993,342:1255-1262.
